Ozempic vs Wegovy
Editorial comparison of Ozempic (semaglutide) and Wegovy (semaglutide). Same drug class context, trial-anchored data, no marketing claims.
Side-by-side
| Dimension | Ozempic | Wegovy |
|---|---|---|
| Generic name | semaglutide | semaglutide |
| Manufacturer | Novo Nordisk | Novo Nordisk |
| FDA approved | 2017 | 2021 |
| Mechanism | Same mechanism as Wegovy — GLP-1 receptor agonist. | Semaglutide mimics GLP-1, a gut hormone released after meals. |
| Dosing | 0.25mg weekly for 4 weeks, then 0.5mg, then 1mg, max 2mg. Lower max dose than Wegovy (2.4mg). | Titrated over 4-5 months: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg, increasing every 4 weeks. |
| Cost | List price ~$900-1,000/month. | List price ~$1,350/month without insurance. |
| Pivotal trial result | 1.4–1.8% HbA1c reduction across SUSTAIN trials (1.0 mg dose) | 14.9% mean body-weight reduction at 68 weeks |
Efficacy in the trials
1.4–1.8% HbA1c reduction across SUSTAIN trials (1.0 mg dose)
SUSTAIN-6 (NCT01720446) — cardiovascular outcomes · vs placebo, 26% reduction in major adverse cardiovascular events · n=3,297
14.9% mean body-weight reduction at 68 weeks
STEP 1 (NCT03548935) · vs 2.4% with placebo + lifestyle · n=1,961
Trial averages describe study populations, not individuals. Response varies with the dose tolerated, adherence, and personal physiology; the two drugs were not necessarily tested head-to-head in the same trial.
The details
Dosing & cadence
Cost & access
Side effects
Which should you choose?
If maximizing average trial weight loss is the priority, Wegovy posted the higher pivotal-trial figure; Ozempic still produced clinically meaningful loss and some people tolerate it better. On cost and access, compare each drug's manufacturer direct-pay and insurance path — that often matters more month-to-month than the efficacy gap. Both carry class safety considerations (see each drug's boxed-warning and contraindications); a personal or family history of medullary thyroid carcinoma or MEN2 rules out the GLP-1 class. Bring this comparison to a prescriber, who will match the drug to your history and titrate the dose.
This is editorial framing, not a prescription. The right choice depends on your medical history, insurance, and a clinician's evaluation.
Full Ozempic review →
FDA-approved semaglutide for type 2 diabetes. Widely used off-label for weight loss.
Full Wegovy review →
Once-weekly injectable semaglutide for chronic weight management. ~15% body weight loss in trials.
Deciding at the molecule level? Semaglutide vs Tirzepatide compares the two drug families behind every major GLP-1 brand.
Frequently asked
Is Ozempic or Wegovy more effective?+
In their pivotal trials, Ozempic reported 1.4–1.8% HbA1c reduction across SUSTAIN trials (1.0 mg dose), while Wegovy reported 14.9% mean body-weight reduction at 68 weeks. Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.
How do Ozempic and Wegovy compare on cost?+
Ozempic: List price ~$900-1,000/month. Diabetes coverage is generally better than weight-loss coverage — many insurance plans cover Ozempic with a T2D diagnosis at standard copay. Wegovy: List price ~$1,350/month without insurance. With Novo Nordisk's patient assistance program, eligible self-pay patients can access at $200-500/month. Insurance coverage is patchy and often requires prior authorization plus a documented weight-related comorbidity. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.
Can I switch from Ozempic to Wegovy?+
Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.
Are Ozempic and Wegovy the same drug?+
No. Ozempic (semaglutide) and Wegovy (semaglutide) are distinct medications from Novo Nordisk and Novo Nordisk respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.